Navigation Links
Pfizer Says Nigeria Gave Approval for 1996 Drug Test

US drug giant Pfizer Thursday said it had got the go-ahead from Nigerian authorities before administering a drug that claimed the lives of 11 children in the northern Kano state in 1996.

"We have written approvals from NAFDAC (Nigeria's drug agency), the federal ministry of health, Kano government and parents or guardians of the children before the clinical test of the drug was carried out," managing director of Pfizer Specialities Limited Nigeria Ngozi Edozien told reporters.

The Nigerian federal government and Kano state government have filed two separate suits against Pfizer, claiming around some 9.5 billion dollars in damages for victims of the failed drug test.

Both governments accuse Pfizer of administering a test antibiotic called Trovan without authorisation or parental consent among children at a field hospital during an epidemic of meningitis, measles and cholera.

Of the 200 children affected, 11 died while many more -- reportedly 181 -- suffered from deafness, paralysis, brain damage and blindness, according to the allegations. Pfizer denies the charges.

Edozien said Pfizer carried out the test following "an appeal for help" from Nigeria.

She said Trovan as an oral application was the best drug to treat those disease and underlined that Pfizer meant no harm.

The US Food and Drug Administration cleared Trovan for adult use in 1997 and the drug swiftly became established as one of the most prescribed antibiotics in the US market.

She said the company would defend itself against the suits during the next hearing.

The Nigerian federal government filed its suit on June 4 in Abuja for almost seven billion dollars in damages against the US drug firm, while Kano is asking for 2.5 billion dollars.

The federal suit comes up on July 20 while that of Kano government has been fixed for October 3.


'"/>




Page: 1

Related medicine news :

1. Pfizer unveils anti-smoking drug
2. The Effectiveness Of The Breast Cancer Drug By Pfizer
3. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
4. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
5. Pfizer’s Eraxis Approved By The FD
6. Pfizer Launches Viagra For Lung Disease In UK
7. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
8. Pfizer Commences Its Advertising for Celebrex with All the Warnings
9. FDA Approves Pfizer’s Anti-smoking Dru
10. Pfizer vouches safety of long-term inhaled insulin.
11. NICE Setback Rules for Pfizers Inhaled Insulin
Post Your Comments:
(Date:12/2/2008)...ay be better spent in other areas, experts say , ...pital rapid response teams, created to prevent car... do not seem to work, a new study finds. , "Man...past decade," said lead researcher Dr. Paul S. Cha...te in Kansas City, Mo. "Earlier studies had shown ...
(Date:12/2/2008)... The Health Story Project was an...t formerly known as “Clinical Document Archi.... CDA4CDT will continue as the label for the techn...ted to Health Level Seven (HL7) for ballot. The ne...s Wire EON) December 2, 2008 -- "Our group h...
(Date:12/2/2008)...by specialists from the USC Viterbi School of Engi...nover times for operating rooms at three Californi...of daytime surgery per year." Because of the succe...clude three more hospitals. , A team from the Vi...d Systems Engineering began work in January, 2008 ...
(Date:12/2/2008)..., WASHINGTON, Dec. 2 /PRNewswire-USNewswire/ -...ill deliver the Keynote address at eHealth Initiat...ng the Pulse of Health IT: A Critical Review of Pr...tions for 2009 and Beyond." , , (Logo: htt...) , , The Keynote speech will begin at 4:30...
Breaking Medicine News(10 mins):Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Operations engineering for more efficient operating rooms 2Health News:Operations engineering for more efficient operating rooms 3
... have died of anthrax in Orissa's tribal dominated...deadly disease in the last two days, health offic...e and Nanda Jani, 35, of Padiguda village under Se...early 500 km from Bhubaneswar, fell to the disease...
...A.P.J. Abdul Kalam Friday urge the nation's doctor...cation at the Post-Graduate Institute of Medical S...ke medical facilities available for village India.... the zeal to treat at least 20 rural patients a ye...
...rdiologist Naresh Trehan has been reinstated as ex...owing an out-of-court settlement ending their week...is Healthcare, which has acquired 90 percent stake...Research Centre (EHIRC), Saturday withdrew the pol...
...e developed by the American Academy of Neurology f...tics are highly effective for treating nervous sys... evidence that prolonged treatment with antibiotic...st following standard therapy. The guideline is pu...
Other Medicine News:Health News:Naresh Trehan Reinstated as Chief of Escorts After Weeklong Row 2Health News:Antibiotics Highly Effective for Treating Lyme Disease 2
(Date:12/1/2008)... today announced the initiation of a Phase 1/2 cli...JAK2 inhibitor, in leading medical centers in Aust...brosis (CIMF). , , The trial is designed t...n patients with CIMF and is expected to enrol up t... assess the safety profile and evaluate the pharma...
(Date:12/1/2008)...y switch that, if turned off, causes lymphatic end...e their identity and become more like blood endoth...ewswire-USNewswire/ -- Scientists at St. Jude Chi...ertain differentiated cell type is so ready to cha...ression of a gene called Prox1 to dissuade it. ...
(Date:12/1/2008)...FirstCall/ -- Following a,Request for Proposal is...ed,third generation smallpox vaccine, Public Wor...he Canadian Department of National Defence, has aw...ery of IMVAMUNE(R). , The Canadian authorit...try,s bio-preparedness programme. , The con...
(Date:12/1/2008)...al Incorporated (Nasdaq: VICL ) announced today ...om Merck & Co., Inc. based on Merck,s planned ...tigational plasmid DNA (pDNA) cancer vaccine. The ...ivery technology and encodes human telomerase reve... separate license agreement. , , "The bread...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 1Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 2Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 3Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 1Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 2Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 3Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 4Significant Anti Tumor Activity of NKTR 102 in Patients With Refractory Solid Tumors 3B Interim Data Published in ASCO 2008 Proceedings 2098 5Anesiva Announces May 22 2008 Presentation at Citi Investment Research Global HealthCare Conference 19576 1Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 1Oncolytics Biotech Inc Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 5470 2
...TH SAN FRANCISCO, Calif., June 01, 2007,/PRNewswir...y,announced that the company will present data fro...at the 12th Congress of the European,Hematology As...na,Austria. , Presentations will include updated ...rial of SNS-595 in acute leukemias, as,well as cli...
...ich, June 1, 2007-Cytos Biotechnology AG is deligh...esentations of its novel,immunotherapeutic CYT003-...ve clinical results for CYT003-QbG10 were obtained...e XXVI Congress of,the European Academy of Allergo... from June 9-13, 2007 in Göteborg,Sweden. Th...
Other Medicine Technology:Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 2Sunesis Pharmaceuticals to Present Data at the 12th Congress of the,European Hematology Association 3CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007 2
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: